Ari Raphael
- 4.5 Buono • 155 recensioni
- 29 anni di esperienza
- accreditamenti:
- Israel, Tel Aviv, Sourasky Medical Center (Ichilov)
Dr. Ari Raphael leads groundbreaking research in lung and breast cancer at Sourasky Medical Center, with a focus on genomic medicine and immunotherapy.
- Primary investigator for clinical trials on pembrolizumab and neoadjuvant immunotherapy
- Expert in comprehensive genomic profiling and liquid biopsies
- Moderates the Molecular Tumor Board for the Israeli Lung Cancer Society
- Outstanding teacher at Tel-Aviv University's Faculty of Medicine
- Mostra di più